Treatment and clinical outcomes of patients relapsing after allogeneic hematopoietic cell transplantation for myelodysplastic syndrome.
Conclusion: Outcomes of MDS patients relapsing after allogeneic HCT were disappointing. Some patients could be saved using DLI or second HCT.
PMID: 30588465 [PubMed]
Source: Blood Research - Category: Hematology Tags: Blood Res Source Type: research